Valuation: UCB

Market Cap 44.26B 50.65B 40.91B 37.8B 71.18B 4,865B 72.47B 488B 191B 2,382B 190B 186B 8,202B P/E 2026 *
25.5x
P/E 2027 * 20.1x
Enterprise Value 43.99B 50.33B 40.66B 37.57B 70.75B 4,835B 72.03B 485B 190B 2,367B 189B 185B 8,152B EV / Sales 2026 *
5.15x
EV / Sales 2027 * 4.35x
Free-Float
61.59%
Yield 2026 *
0.62%
Yield 2027 * 0.64%
1 day-1.32%
1 week-8.61%
Current month-11.26%
1 month-15.42%
3 months-15.15%
6 months-8.54%
Current year-2.56%
1 week 230.7
Extreme 230.7
254.3
1 month 230.7
Extreme 230.7
272.2
Current year 223
Extreme 223
289.5
1 year 168.7
Extreme 168.7
289.5
3 years 65.4
Extreme 65.4
289.5
5 years 65.4
Extreme 65.4
289.5
10 years 54.84
Extreme 54.84
289.5
Manager TitleAgeSince
Chief Executive Officer 67 2014-12-31
Director of Finance/CFO 59 2020-06-30
Chief Tech/Sci/R&D Officer 59 2024-04-30
Director TitleAgeSince
Director/Board Member 55 2011-12-31
Director/Board Member 67 2014-12-31
Director/Board Member 56 2014-04-23
Date Insider Type Main position Quantity % Market Cap.
Jan. 14Fiscal year

Executive/Senior Manager

3,000 0.0015%
Jan. 14Buy

Director

500 0.0003%
Jan. 14Fiscal year

Executive/Senior Manager

3,000 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-1.32%-8.61%+36.00%+195.88% 51.13B
-1.05%-2.97%+14.99%-8.68% 67.46B
-2.29%+36.80%+36.80%+36.80% 43.4B
+1.34%-1.02%-48.96%-53.51% 40.32B
-8.17%-6.68%+44.20%-31.18% 30.86B
+0.64%-15.46%+105.17%-44.43% 26.59B
+0.57%-2.69%+64.16%+86.01% 22.82B
+1.07%-0.50%+11.79%+175.38% 19.79B
-1.56%-5.38%+53.69%+123.21% 16.47B
+1.22%+7.93%+76.33%+361.53% 16.29B
Average -0.98%-2.39%+39.42%+84.10% 33.51B
Weighted average by Cap. -1.18%-2.32%+31.21%+59.91%

Financials

2026 *2027 *
Net sales 8.53B 9.76B 7.89B 7.29B 13.72B 938B 13.97B 94.08B 36.91B 459B 36.68B 35.87B 1,581B 9.63B 11.02B 8.91B 8.23B 15.5B 1,059B 15.78B 106B 41.67B 519B 41.41B 40.5B 1,785B
Net income 1.75B 2B 1.62B 1.5B 2.82B 192B 2.87B 19.3B 7.57B 94.24B 7.53B 7.36B 324B 2.27B 2.6B 2.1B 1.94B 3.66B 250B 3.72B 25.06B 9.83B 122B 9.77B 9.56B 421B
Net Debt -271M -310M -251M -232M -436M -29.82B -444M -2.99B -1.17B -14.6B -1.17B -1.14B -50.28B -2.31B -2.65B -2.14B -1.98B -3.72B -254B -3.79B -25.5B -10B -124B -9.94B -9.72B -429B
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,765
Date Price Change Volume
26-07-14 232.50 -1.32% 152,960
26-07-13 €235.60 -0.63% 192,311
26-07-10 €237.10 -5.16% 222,991
26-07-09 €250.00 +0.52% 266,649
26-07-08 €248.70 -2.01% 303,577
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
235.60EUR
Average target price
287.95EUR
Spread / Average Target
+22.22%

Quarterly revenue - Rate of surprise